In testimony before the U.S. Congress on Tuesday, Dr. Anthony Fauci said researchers could develop a new coronavaccineeby vaccine by the end of the year,media BGR reported. On top of that, Mr. Fauci is cautiously optimistic that an effective vaccine will emerge early next year. While vaccines may be the only way to actually defeat the new coronavirus, some promising progress has been made in drugs that can alleviate some of the more serious symptoms associated with the virus. Researchers at the University of Minnesota recently found that the drug metformin, used to treat type 2 diabetes, can significantly reduce the mortality rate of women who test positive for COVID-19.
The non-reviewed study found that women who took METFORMin were 21 to 24 percent less likely to die from the new coronavirus than those who did not take the drug. Notably, the researchers’ spending on the drug did not appear to have an effect on men’s ability to resist some of the more severe symptoms of the new coronavirus.
According to a peer-reviewed study released Saturday, women taking the widely used oral diabetes drug metformin may reduce the risk of fatal COVID-19. Of the more than 6,200 adults with diabetes or obesity and commercial insurance who were hospitalized for COVID-19, the number of women who had been prescribed for metformin for 90 days had fewer deaths than women who did not take the drug.
It is important to note that the patients involved in the study already have diabetes. Study co-author Caroline Bramante of the University of Minnesota said: “We know that metformin plays different roles between men and women. In diabetes prevention trials, metformin halved the number of CRPs (inflammatory marker C-reactive proteins) in women. Metformin, an inflammatory protein that worsens COVID-19, can also lower levels of TNF-alpha, she said. She added that studies have shown that metformin may cause women to lower TNF-alpha levels more than men.